The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / October / Mass Spectrometry Imaging Maps Intact Proteins in Tissue
Mass Spectrometry News and Research

Mass Spectrometry Imaging Maps Intact Proteins in Tissue

Localized liquid extraction enables high-resolution imaging of intact proteins

10/21/2026 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Scorecard
  • Quiz
  • Poll

Share

A newly developed mass spectrometry imaging protocol can map intact protein forms in biological tissue at a spatial resolution of approximately 10 micrometers, according to a recent study.

Proteoforms are distinct versions of a protein created through processes such as genetic variation, alternative splicing, and post-translational modification. Their location within tissue can provide information that is lost when samples are homogenized for conventional proteomic analysis.

Manxi Yang and colleagues of the James Tarpo Jr. and Margaret Tarpo Department of Chemistry at Purdue University described a detailed workflow using nanospray desorption electrospray ionization, or nano-DESI, mass spectrometry imaging.

Nano-DESI uses two small glass capillaries to form a continuously flowing liquid bridge on the tissue surface. One capillary delivers an extraction solvent, while the second transfers the extracted molecules to the mass spectrometer. Moving the tissue beneath the probe line by line creates a molecular map of the sampled region.

Before imaging, the protocol uses a series of ethanol and chloroform washes to remove lipids from fresh-frozen tissue sections. Lipids ionize efficiently and can suppress protein signals. The ethanol washes also precipitate proteins within the tissue, helping to limit their movement during delipidation.

A shear-force probe maintains a constant distance between the nano-DESI probe and the tissue. This helps stabilize the liquid bridge and prevents the sampling capillaries from touching or damaging the surface. The authors used a sampling tip of approximately 10 micrometers, a stage speed of around 10 micrometers per second and line spacing of approximately 7 micrometers.

The extraction solvent contained acetonitrile, water, and formic acid. Proteins extracted directly from the tissue produced multiply charged ions, which are suitable for top-down tandem mass spectrometry. Proteoforms were identified by comparing their intact masses and fragmentation patterns with database records.

Representative images from mouse brain tissue showed the spatial distributions of several proteoforms, including modified forms of myelin basic protein, acyl-CoA-binding protein, cytochrome c oxidase subunit 6B1, and cytoplasmic dynein light chain 2. Targeted tandem mass spectrometry can be performed on an adjacent tissue section after imaging identifies regions of interest.

The method provides spatial information on intact proteins and their modifications without requiring labels. It could support studies examining how closely related proteoforms are distributed across different tissue structures.

Current nano-DESI experiments typically detect tens of proteoforms, not the full tissue proteome. Most reported targets are abundant proteins smaller than 20 kilodaltons, although larger proteins have been measured in other studies. The authors’ previous work mapped approximately 40 proteoforms representing 19 proteins in rat brain tissue.

Higher spatial resolution also reduces the amount of material collected from each location, weakening protein signals. Tissue thickness can partially offset this loss, but thicker sections may make the surface less uniform and increase the risk of blocking the small capillaries. The authors identified sensitivity, ionization efficiency, spectral processing, and fragmentation as areas for further improvement.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

 This Week’s Mass Spec News
Mass Spectrometry
This Week’s Mass Spec News

April 4, 2025

2 min read

 What If Computers Could Smell?
Mass Spectrometry
What If Computers Could Smell?

April 3, 2025

13 min read

Computers can “see” and “hear,” but fully digitizing scent has so far eluded science – but that may soon change

The Analytical Scientist Innovation Awards 2024: #6
Mass Spectrometry
The Analytical Scientist Innovation Awards 2024: #6

December 3, 2024

3 min read

Syft Technologies’ William Pelet introduces the Syft Explorer – the world's first fully mobile, real-time, and direct trace gas analyzer

The Analytical Scientist Innovation Awards 2024: #4
Mass Spectrometry
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.